top of page
  • Writer's pictureRob Neilson

Revitalist and Wake Network Launch Psychedelic Retreats




Practitioners and Clients Providing Immersive Therapies and Trainings

The newly established retreats by Revitalist and Wake Network are designed to provide a holistic, clinical psychedelic experience. These programs are aimed at participants seeking treatment for mental health issues, traumatic brain injuries, pain, addiction, and palliative care.


Continue on your trip...

Revitalist and Wake Network Partner to Offer Clinical Psychedelic Retreats in the British Virgin Islands

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), a leader in mental health and wellness, has announced a significant partnership with Wake Network, Inc., a pioneer in psychedelic therapeutics. Together, they will launch immersive psychedelic retreats in the British Virgin Islands starting July 2024.

A New Era of Psychedelic Therapy

Comprehensive Care for Diverse Needs

The newly established retreats by Revitalist and Wake Network are designed to provide a holistic, clinical psychedelic experience. These programs are aimed at participants seeking treatment for mental health issues, traumatic brain injuries, pain, addiction, and palliative care.

Specialized Training for Medical Practitioners

In addition to patient care, the retreats will offer advanced training for medical practitioners in the psychedelic field. This training encompasses medical, research, and therapeutic specializations, thus expanding access to high-quality psychedelic therapies, including ketamine and psilocybin treatments.

Strategic Partnership for Enhanced Access

Leveraging Expertise for Standardized Care

Revitalist and Wake Network’s collaboration combines their respective strengths in clinical expertise and psychedelic product development. Revitalist CEO Kathryn A. Walker emphasized the focus on creating standardized care protocols both in the United States and internationally. Walker will personally oversee the retreats, ensuring the highest standards of care.

Pre-Retreat and Post-Retreat Support

Participants will engage in virtual group meetings and one-on-one sessions before arriving at the retreat to prepare using established protocols. The retreats will be conducted in a legal psilocybin setting, with medical professionals ensuring ethical and safety standards. After the retreat, participants will receive integration support to process their experiences and develop sustainable personal growth practices.

Wake Network’s Role in Psychedelic Advancement

Wake Network’s Contributions

Wake Network, a leader in naturally-derived psilocybin production and neuroregenerative mushroom supplements, will play a pivotal role in this partnership. Their remote neuro-advancement wellness platform, “WakeWell,” will be integral to the retreat experience.

Expanding Access and Training

Wake Network CEO Nick Murray highlighted the need for expert training and care in the psychedelic field. By partnering with Revitalist, Wake Network aims to expand its services, providing comprehensive care and support through their harm reduction model.

More Information and Contact Details

For further details on the psychedelic retreats, visit Revitalist’s retreat page or Wake Network’s retreat page.

About Wake Network, Inc. Wake Network, Inc. is at the forefront of advancing psychedelic and fungi-based therapeutics. Their offerings include functional and psilocybin medicinal products combined with the WakeWell online wellness platform, supporting personalized mental wellness through evidence-based protocols.

Contact Information:

About Revitalist Lifestyle and Wellness Ltd.  Revitalist Lifestyle and Wellness Ltd. is dedicated to comprehensive care in the ketamine wellness space, offering innovative, evidence-based services through physical and virtual offices across 35 states. Led by Kathryn Walker, an advanced provider in the psychedelic space, Revitalist is a leader in this emerging field.

Visit Revitalistclinic.com for more information.

Forward-Looking Statements

This news release contains forward-looking statements based on expectations and assumptions about the Company’s business plans, partnership benefits, and market position in the ketamine wellness sector. These statements involve inherent risks and uncertainties, and actual results may differ materially. The Company undertakes no obligation to update these statements unless required by law. For more details, refer to the Company’s management’s discussion and analysis for the nine-month period ended September 30, 2022, available on sedarplus.ca.


Madison Roberts is a nomadic journalist exploring the intersections of cutting-edge science, tech and human well-being. She immerses in diverse cultures, uncovering compelling stories in biotech, neuropsychiatry, neuroscience, mental health, psychedelics and longevity research. Her writing blends scientific rigor with human narratives, resonating across readers. Passionate about the brain's intricacies and psychedelics' healing potential, she's a thought-provoking, empathetic storyteller. Between interviews and breakthroughs, Madison cherishes tranquil moments exploring new landscapes.

30 views0 comments

Comments


bottom of page